Previous 10 | Next 10 |
home / stock / tdsgf / tdsgf news
2023-10-17 09:15:48 ET Palm Beach, FL – October 17, 2023 – FinancialNewsMedia.com News Commentary – Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight infections. The US mult...
TeloView Analyses Telomeres to Accurately Predict and Characterize Multiple Myeloma Toronto, Ontario--(Newsfile Corp. - October 17, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") today announced the launch of its TeloViewSMM to clinicians in the United States. ...
Toronto, Ontario--(Newsfile Corp. - October 12, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "TELO") is pleased to announce that it has participated in the International Myeloma Society ("IMS") annual meeting that took place in Athens, Greece during the last wee...
Toronto, Ontario--(Newsfile Corp. - September 6, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the " Company " or " Telo ") is proud to announce that it has successfully completed the final assessment and achieved ISO 15189 accreditation. ISO 15189 is the international st...
Toronto, Ontario--(Newsfile Corp. - August 29, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to provide an update on the planned launch of the TeloView®SMM (Smoldering Multiple Myeloma) assay in the fourth quarter of this year. The test will be ...
2023-06-30 09:59:22 ET Telo Genomics ( OTCQB:TDSGF ) has entered into an agreement with Leede Jones Gable to compensate Leede for strategic advice provided in connection with the Company's recently closed $0.25 non-brokered private placement. Under the agreement, the Co. will ...
Toronto, Ontario--(Newsfile Corp. - June 30, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the " Company " or " TELO ") announces that it has entered into an agreement with Leede Jones Gable Inc. (" Leede ") to compensate Leede for strategic advice provided in connection with the Com...
Toronto, Ontario--(Newsfile Corp. - June 14, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the " Company " or " Telo ") announces that it has closed its previously announced non-brokered private placement (" Offering ") of units (the " Units "). The Company issued a total of 11,335...
Toronto, Ontario--(Newsfile Corp. - June 12, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") presented the results of its latest study on Friday June 09, 2023 at the European Hematology Association (EHA) 2023 annual meeting. This study, executed in conjunct...
Toronto, Ontario--(Newsfile Corp. - June 6, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the " Company " or " TELO ") is pleased to announce that it has increased the size of its previously announced non-brokered private placement (" Offering ") from up to $2 million in proceeds to ...
News, Short Squeeze, Breakout and More Instantly...
Teledata Singapore Ltd Company Name:
TDSGF Stock Symbol:
OTCMKTS Market:
Toronto, Ontario--(Newsfile Corp. - May 15, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications in oncology is pleased to announce that ...
Toronto, Ontario--(Newsfile Corp. - April 10, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncol...
Toronto, Ontario--(Newsfile Corp. - April 2, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncolo...